Additionally, the immunoreactive score (IRS) of MMP-13 was suitable for evaluating the pathologic grade of precancerous and cancerous colorectal lesions, showing that MMP-13 can be applied to stratification of prognosis as an excellent marker of CRC [105]. This evidence concerns the gene MMP13 and colorectal carcinoma.